ci 953 has been researched along with carbamazepine in 1 studies
Studies (ci 953) | Trials (ci 953) | Recent Studies (post-2010) (ci 953) | Studies (carbamazepine) | Trials (carbamazepine) | Recent Studies (post-2010) (carbamazepine) |
---|---|---|---|---|---|
5 | 0 | 3 | 11,992 | 1,128 | 3,101 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Catterall, WA; Macdonald, RL; McLean, MJ; Rock, DM; Taylor, CP | 1 |
1 other study(ies) available for ci 953 and carbamazepine
Article | Year |
---|---|
Ralitoline (CI-946) and CI-953 block sustained repetitive sodium action potentials in cultured mouse spinal cord neurons and displace batrachotoxinin A 20-alpha-benzoate binding in vitro.
Topics: Action Potentials; Animals; Anticonvulsants; Batrachotoxins; Carbamazepine; Cells, Cultured; Electrophysiology; Epilepsy; Kinetics; Mice; Neurons; Phenylurea Compounds; Phenytoin; Radioligand Assay; Sodium Channels; Spinal Cord; Synaptosomes; Thiazoles | 1991 |